missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Description
Immunogen sequence: KEEKVKEPKQ SQSPAPIKQL EDLPMSIEEW ASYSCPEEVL SVLKQDRSDS TVNPSSIQKP TYSLYFLDHL Highest antigen sequence identity to the following orthologs: Mouse - 59%, Rat - 31%.
The TTC40 gene, which stands for Tetratricopeptide repeat domain 40, is a member of the TPR protein family characterized by highly conserved motifs that facilitate protein-protein interactions. This gene plays a significant role in various cellular processes, including signal transduction and protein assembly. TTC40 has been identified as a novel methylated gene in nasopharyngeal carcinoma, where its expression is significantly reduced in tumor tissues due to hypermethylation. This epigenetic alteration suggests a potential role of TTC40 in tumorigenesis, possibly acting as a tumor suppressor. The decreased expression of TTC40 in cancerous tissues highlights its importance in maintaining cellular homeostasis and integrity.
Specifications
Specifications
| Antigen | TTC40 |
| Applications | Immunohistochemistry (Paraffin) |
| Classification | Polyclonal |
| Concentration | 0.1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 |
| Gene | CFAP46 |
| Gene Accession No. | Q8IYW2 |
| Gene Alias | 9330101J02Rik; bA288G11.4; bA288G11.5; bB137A17.2; bB137A17.3; C10orf123; C10orf124; C10orf92; C10orf93; CFAP46; cilia and flagella associated protein 46; cilia- and flagella-associated protein 46; E030019B06Rik; Gm170; protein CFAP46; RGD1559985; similar to chromosome 10 open reading frame 92; tetratricopeptide repeat domain 40; tetratricopeptide repeat protein 40; TPR repeat-containing protein C10orf93; TTC40 |
| Gene Symbols | CFAP46 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?
